Heidelberg Ion Therapy Center
Heidelberg University Hospital has long been a leader in advancements in clinical, physics, and radiobiological research. The HIT itself is a world class ion therapy center originally opened in 2009 that is one of very few centers in the world treating patients with both proton and carbon ion therapy. The HIT treats a diverse group of patients from Germany, elsewhere in Europe, and around the world. These patients often arrive at the HIT with radioresistant tumor histologies, locally advanced tumors, and/or tumors adjacent to radiosensitive critical structures in the CNS, head & neck, and pelvis. Additionally, a large cohort of pediatric patients is treated at HIT with a variety of rare malignancies.
- ACRO will provide two $2,000 travel grants for radiation oncology trainees for a 1-month elective at the HIT in Heidelberg, Germany.
- Awardees tentative dates of travel should be between March and August 2020 (later dates also considered).
- The planned dates of travel must occur while the applicant remains an active resident or during the first two years upon completion of residency.
- Expenses exceeding the scholarship funds will be the responsibility of the scholarship recipient.
- Depending on the length of the trip, activities pursued, and the time of year selected for travel, total costs will likely exceed the scholarship funds.
- Subsidized housing is available through the Heidelberg University Hospital for eligible rotating physicians. Appropriate housing officials should be contacted well in advance of rotation to reserve a room.
- Written certification of personal permission to travel internationally by the applicant’s Graduate Medical Education (GME) office AND chairman/program director is required (see details below).
- For those selected to receive the ACRO HIT Scholarship, additional paperwork for the HIT, proof of individual travel and medical-evacuation insurance are required prior to distribution of funds (see details below).
- Awardees will provide a written summary with high-resolution photos of their elective rotation for ACRO publications. In addition, awardees will present an account of their experience at the ACRO Annual Meeting following their elective rotation. Recipients must make all arrangements to attend the meeting.
- Final acceptance and disbursement of funds is subject to review and final approval by ACRO and the Heidelberg University Hospital.
- Failure to comply with program requirements may be subject to award revocation at the discretion of the ACRO Board of Chancellors and ACRO Resident Committee.
- ACRO Membership: Applicants must be members of ACRO and in good standing at a US radiation oncology residency or fellowship program. Applications for membership can be found at http://www.acro.org/Membership.
- Submission Requirements: All submissions must include the following:
- Application Form (below)
- Applicant’s Curriculum Vitae
- Personal Statement
- Letters of Support from:
- Radiation Oncology program chairman or program director
- Home institution GME office
- Submission deadline: The application deadline was March 24, 2020 and additional submissions are not being accepted at this time.
- Submissions will be assessed and scholarships will be awarded by members of the ACRO Resident Committee with input from the Board of Chancellors and HIT as needed.
2019: Rohit Gunan Ganju, MD, Univ. of Kansas
2019: Matthew Susko, MD, UCSF
2018: Benjamin Farnia, MD
2018: Jacqueline Kelly, MD
2016: William Tristram Arscott, MD
2016: Samuel Marcrom, MD
2015: Michael Repka, MD
2015: Vivek Verma, MD